Skip to search formSkip to main contentSkip to account menu

squamosamide

Known as: Benzeneacetamide, 4-hydroxy-alpha-((4-hydroxy-3-methoxyphenyl)methylene)-N-(2-(4-hydroxyphenyl)ethyl)-3,5-dimethoxy-, (E)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
AbstractAim:The aim of this study was to study the effects of compound FLZ, a novel cyclic derivative of squamosamide from Annona… 
2009
2009
AbstractAim:The aim of this study was to investigate the effect of the squamosamide derivative FLZ (N-2-(4-hydroxy-phenyl)-ethyl… 
2008
2008
BackgroundInflammation plays an important role in the pathogenesis of Parkinson's disease (PD) through over-activation of… 
2008
2008
AbstractAim:The aim of the present study was to investigate the protective effect of compound N-[2-(4-hydroxy-phenyl)-ethyl]-2-(2… 
2007
2007
The aim of the present study was to access the protective effect of a novel synthesized squamosamide cyclic analogue, compound… 
Review
2007
Review
2007
FLZ is a synthetic new derivative of squamosamide. Pharmacological study found that FLZ given orally improved the abnormal… 
2006
2006
AbstractAim:To study the protective effects of compound FLZ, a novel synthetic analogue of natural squamosamide, on learning and… 
2004
2004
OBJECTIVE To design and synthesize a series of squamosamide cyclic analogues and to test their antioxidation activity. METHODS…